Literature DB >> 7814628

Cellular and molecular basis of human gamma delta T cell activation. Role of accessory molecules in alloactivation.

M Takamizawa1, F Fagnoni, A Mehta-Damani, A Rivas, E G Engleman.   

Abstract

Although gamma delta T cell receptor-bearing lymphocytes (gamma delta T cells) constitute a significant minority of circulating and tissue-associated T lymphocytes, the mechanism responsible for the activation of these cells is unknown. To address this question, resting gamma delta TCR+, CD3+, CD4-, CD8- cells isolated from the blood of healthy volunteers were cultured with allogeneic dendritic cells (DC) or monocytes, and their proliferative response measured. DC alone induced gamma delta T cells to proliferate, with a peak response on the sixth day of culture. Pretreatment of DC with an anti-HLA-DR mAb, but not anti-HLA class I or anti-CD1 mAbs, inhibited the response of gamma delta T cells. Antibodies to gamma delta T cell receptor, CD2, CD3, or CD11a were also inhibitory, whereas antibodies to alpha beta T cell receptor, CD4, CD5, and CD8 had no effect. Although only 40-60% of freshly isolated gamma delta T cells expressed CD28, mAbs directed against CD28 or its ligand, CD80, were markedly inhibitory. Moreover, removal of CD28+ cells from the gamma delta T cell population nearly abrogated the response to DC. These results demonstrate that resting gamma delta T cells recognize and respond to MHC class II determinants on allogeneic DC in a manner that is highly dependent on the CD28 activation pathway as well as molecules such as CD2 and CD11a that mediate cell-to-cell adhesion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7814628      PMCID: PMC295431          DOI: 10.1172/JCI117654

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region.

Authors:  C J Rust; F Verreck; H Vietor; F Koning
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

2.  Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.

Authors:  J L Ceuppens; M L Baroja
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence.

Authors:  D T Sasaki; S E Dumas; E G Engleman
Journal:  Cytometry       Date:  1987-07

Review 4.  The role of the CD28 receptor during T cell responses to antigen.

Authors:  P S Linsley; J A Ledbetter
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

5.  B70 antigen is a second ligand for CTLA-4 and CD28.

Authors:  M Azuma; D Ito; H Yagita; K Okumura; J H Phillips; L L Lanier; C Somoza
Journal:  Nature       Date:  1993-11-04       Impact factor: 49.962

6.  Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen.

Authors:  P Mombaerts; J Arnoldi; F Russ; S Tonegawa; S H Kaufmann
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

7.  The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro.

Authors:  J W Young; L Koulova; S A Soergel; E A Clark; R M Steinman; B Dupont
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 8.  Gamma/delta cells.

Authors:  W Haas; P Pereira; S Tonegawa
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.

Authors:  E G Engleman; C J Benike; F C Grumet; R L Evans
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  10 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

Review 2.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

3.  Afferent lymph veiled cells stimulate proliferative responses in allogeneic CD4+ and CD8+ T cells but not gamma delta TCR+ T cells.

Authors:  C J Howard; P Sopp; J Brownlie; K R Parsons; L S Kwong; R A Collins
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  The surface epithelium of recurrent infected palatine tonsils is rich in gammadelta T cells.

Authors:  K Olofsson; S Hellström; M L Hammarström
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

Review 5.  Dendritic cells: potential role in cancer therapy.

Authors:  E G Engleman
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

6.  Co-stimulatory signals increase the reactivity of gammadelta T cells towards mycobacterial antigens.

Authors:  R González-Amaro; D P Portales-Pérez; L Baranda; B Moncada; C Toro; S López-Briones; C Espitia; R Mancilla
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

7.  Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.

Authors:  M J Maeurer; D Martin; W Walter; K Liu; L Zitvogel; K Halusczcak; H Rabinowich; R Duquesnoy; W Storkus; M T Lotze
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 8.  Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

Authors:  Florian Wimmers; Gerty Schreibelt; Annette E Sköld; Carl G Figdor; I Jolanda M De Vries
Journal:  Front Immunol       Date:  2014-04-11       Impact factor: 7.561

Review 9.  Ligand recognition by the γδ TCR and discrimination between homeostasis and stress conditions.

Authors:  Malte Deseke; Immo Prinz
Journal:  Cell Mol Immunol       Date:  2020-07-24       Impact factor: 11.530

Review 10.  Empowering gamma delta T cells with antitumor immunity by dendritic cell-based immunotherapy.

Authors:  Heleen H Van Acker; Sébastien Anguille; Viggo F Van Tendeloo; Eva Lion
Journal:  Oncoimmunology       Date:  2015-04-01       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.